Table 2.
Baseline sociodemographic, clinical, and psychological characteristics of samples of meningioma patients at each timepoint
| Baseline Characteristics | T0 (n = 261) | T3 (n = 229) | T12 (n = 82) | Dropout T12 (n = 147) |
|---|---|---|---|---|
| Sociodemographic characteristics | ||||
| Age, y: mean ± SD (range) | 57.8 ± 11.7 (23–82) | 57.1 ± 11.7 (23–82) | 55.9 ± 10.7 (32–75) | 58.7 ± 12.0 (23–82) |
| Education, y: mean ± SD (range) | 13.7 ± 3.7 (6–26) | 14.0 ± 3.7 (6–26) | 14.4 ± 3.7 (8–26) | 13.5 ± 3.7 (6–22) |
| Sex: female/male n(%) | 189(72)/72(28) | 167(73) / 62(27) | 59(72) / 23(28) | 130(73)/49(27) |
| Clinical characteristics | ||||
| WHO grade: I/II n(%) | 240(92) / 21(8) | 211(92) / 18(8) | 76(93) / 6(7) | 164(92)/15(8) |
| Number of meningioma: 1/≥2 n(%) | 244(94) / 17(6) | 217(95) / 12(5) | 79(96) / 3(4) | 168(94)/11(6) |
| Hemisphere: Left/right/bilateral n(%) | 106(41) / 124(48) / 31(11) | 94(41) / 107(47) / 28(12) | 32(39) / 39(48) / 11(13) | 74(41)/85(48)/20(11) |
| Supratentorial/infratentorial n(%) | 238(91) / 23(9) | 208(91) / 21(9) | 75(91) / 7(9) | 163(91) / 16(9) |
| Frontal/nonfrontal n(%) | 154(59) / 107(41) | 135(59) / 94(41) | 46(56) / 36(44) | 108 (60)/71(40) |
| Tumor volume (cm3): median (range)a | 33.5 (0.45–150.2) | 32.0 (0.45–150.2) | 34.5 (0.45–144.8) | 32.0 (0.62–150.2) |
| ASA score: I, II/III, IV n(%) | 225(86) / 36(14) | 202(88) / 27(12) | 71(87) / 11(13) | 154(86) / 25 (14) |
| Psychotropic medication: yes/no n(%)b | 142(56) / 112(44) | 122(54) / 102(46) | 45(56) / 35(44) | 97 (56) / 77 (44) |
| Psychological characteristics | ||||
| Anxiety HADS: mean ± SD (range)c | 7.2 ± 4.2 (0–20) | 7.0 ± 4.2 (0–19) | 7.0 ± 4.0 (0–17) | 7.3 ± 4.3 (0–20) |
| Depression HADS: mean ± SD (range)c | 5.9 ± 4.6 (0–21) | 5.7 ± 4.5 (0–21) | 6.0 ± 4.9 (0–21) | 5.8 ± 4.5 (0–19) |
a data missing T0 n = 30; T3 = 24; T12 = 6; b data missing T0 n = 7; T3 n = 5; T12 n = 2; c data missing T0 = 32; T3 = 25; T12 = 7.